Cargando…

CD48 is a key molecule of immunomodulation affecting prognosis in glioma

Purpose: Glioma is a refractory disease associated with immune cell infiltration, and the effectiveness of checkpoint blockade remains suboptimal. As an adhesion and costimulatory molecule, CD48 plays a significant role in immunomodulation. As such, studying CD48 may provide additional understanding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Cunyi, Zhu, Chen, Guan, Gefei, Guo, Qing, Liu, Tianqi, Shen, Shuai, Yan, Zihao, Xu, Xiaoyan, Lin, Zhiguo, Chen, Ling, Wu, Anhua, Cheng, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549391/ https://www.ncbi.nlm.nih.gov/pubmed/31213836 http://dx.doi.org/10.2147/OTT.S198762

Ejemplares similares

The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma
por: Han, Yunhe, et al.
Publicado: (2021)

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma
por: Zhu, Chen, et al.
Publicado: (2020)

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy
por: Shen, Shuai, et al.
Publicado: (2020)

Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma
por: Liu, Tianqi, et al.
Publicado: (2022)

Secretory Pathway Kinase FAM20C, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma
por: Du, Shaonan, et al.
Publicado: (2020)

Cancer cell intrinsic TIM-3 induces glioblastoma progression
por: Guo, Qing, et al.
Publicado: (2022)

Characterization of an endoplasmic reticulum stress‐related signature to evaluate immune features and predict prognosis in glioma
por: Zhang, Qing, et al.
Publicado: (2021)

Molecular profiling identifies distinct subtypes across TP53 mutant tumors
por: Chen, Xin, et al.
Publicado: (2022)

Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network
por: Liang, Qingyu, et al.
Publicado: (2019)

LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
por: Zhang, Qing, et al.
Publicado: (2020)

ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL
por: Wang, Yulin, et al.
Publicado: (2018)

Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma
por: Liang, Qingyu, et al.
Publicado: (2020)

Small molecule-based immunomodulators for cancer therapy
por: Wu, Yinrong, et al.
Publicado: (2022)

TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients
por: Wang, Chao, et al.
Publicado: (2010)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma
por: Malo, Courtney S., et al.
Publicado: (2018)

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
por: Yan, Zihao, et al.
Publicado: (2021)

Helminth defence molecules—immunomodulators designed by parasites!
por: Robinson, Mark W., et al.
Publicado: (2013)

Plants and Plant-Derived Molecules as Natural Immunomodulators
por: Zebeaman, Meseret, et al.
Publicado: (2023)

TERT Promoter Mutations Lead to High Transcriptional Activity under Hypoxia and Temozolomide Treatment and Predict Poor Prognosis in Gliomas
por: Chen, Chen, et al.
Publicado: (2014)

Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta‐analysis
por: Feng, Yuan, et al.
Publicado: (2019)

Dynamics of central and peripheral immunomodulation in a murine glioma model
por: Kennedy, Benjamin C, et al.
Publicado: (2009)

Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation
por: Moorman, Hannah R., et al.
Publicado: (2020)

microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma
por: An, Liwen, et al.
Publicado: (2013)

Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
por: Hou, Xiaoying, et al.
Publicado: (2023)

Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs
por: Tomei, Sara, et al.
Publicado: (2021)

Immunomodulation and Biomaterials: Key Players to Repair Volumetric Muscle Loss
por: Kiran, Sonia, et al.
Publicado: (2021)

Viral infection and glioma: a meta-analysis of prognosis
por: Cai, Zehao, et al.
Publicado: (2020)

Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?
por: Cotton, Sophie, et al.
Publicado: (2012)

An Fc Domain Protein–Small Molecule Conjugate as an Enhanced Immunomodulator
por: Chiang, Meng-Jung, et al.
Publicado: (2014)

Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
por: Osipov, Arsen, et al.
Publicado: (2019)

ARL3 is downregulated and acts as a prognostic biomarker in glioma
por: Wang, Yulin, et al.
Publicado: (2019)

Immunomodulating Therapies in Breast Cancer—From Prognosis to Clinical Practice
por: Schmidt, Marcus, et al.
Publicado: (2021)

Multiomics Profiling and Clustering of Low-Grade Gliomas Based on the Integrated Stress Status
por: Ren, Xiaolin, et al.
Publicado: (2021)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma
por: Wu, Hao, et al.
Publicado: (2022)

Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
por: Panek, Wojciech K., et al.
Publicado: (2017)

Correlation of microrna-372 upregulation with poor prognosis in human glioma
por: Li, Gang, et al.
Publicado: (2013)

The toxin mimic FS48 from the salivary gland of Xenopsylla cheopis functions as a Kv1.3 channel-blocking immunomodulator of T cell activation
por: Zeng, Qingye, et al.
Publicado: (2021)

Thymic stromal lymphopoietin is a key cytokine for the immunomodulation of atherogenesis with Freund's adjuvant
por: Steinmetz, Martin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4qt5ggch00vhkoc75gfsi9ce4o